BioInformant

Your Global Leader in Stem Cell Market Research

Home » Press Releases

CBR Announces New Pediatric Genetic Screening Test in Collaboration with Sema4

By Leave a Comment

Sema4 collaborated with CBR to launch ReadyGen™, a genetic screening test that analyzes a child’s DNA for 200+ conditions.

LOS ANGELES, Nov. 15, 2019 — CBR, the global leader in newborn stem cell banking, has announced a new genetic service developed over the past couple of years as part of a strategic alliance with Sema4. As a patient-centered health intelligence company and leading innovator within the genomic testing industry, Sema4 collaborated with CBR to launch ReadyGen™, a highly accurate genetic screening test that analyzes a child’s DNA for more than 200 conditions that can affect children before the age of 10. [Read more…]

Generex Biotechnology Announces First-in-Human Clinical Trial of the ALTuCELL Cellular Therapy Product Altsulin® (Microencapsulated Sertoli Cells)

By Leave a Comment

  • Principal investigator Dr. Jaime Guevara Aguirre, world-renowned expert on growth hormone to conduct the trial of Altsulin® (Microencapsulated Sertoli Cells) in Laron Syndrome Patients

  • Laron Syndrome (aka Laron-type dwarfism) is a rare pediatric orphan disease eligible for the FDA “Golden Ticket”

  • Phase IIa proof-of-concept trial paves the way to commercial development of Sertoli Cells for the treatment of Type I Diabetes

[Read more…]

At the American Academy of Stem Cell Physicians Live Congress 2019, FDA Safety Panel Says No to the Bad Actors

By Leave a Comment

*Photo: Dr. Warren Bleiweiss showing off new AASCP Board Certification.

The American Academy of Stem Cell Physicians hosted a panel on Nov. 2 to discuss safety standards for Physicians who practice stem cell medicine.

MIAMI, November 6, 2019 — The American Academy of Stem Cell Physicians (AASCP) was joined by the the alliance leader Janet Marchibroda in hosting a safety standards panel on November second at the AASCP Live Congress 2019. The panel, which was moderated by Janet Marchibroda, the president of The Alliance for cell therapy now, also attending via Skype Dr Peter Marks director of the Center for Biologics and Evaluation and Research, was well-received by physicians from around the world. [Read more…]

Synthego Launches High-Throughput Induced Pluripotent Stem Cell Genome Engineering

By Leave a Comment

National Institutes of Health awards contract for CRISPR-based disease modeling in iPS cell lines associated with Alzheimer’s, Stem cell pioneer Bill Skarnes joins advisory board

REDWOOD CITY, Calif., Oct. 22, 2019 — Synthego, the leading genome engineering company, announced the launch of genome engineering for induced pluripotent stem (iPS) cells. The new offering expands Synthego’s automated cell editing to achieve unprecedented editing efficiency of iPS cells at an industrial scale. [Read more…]

FUJIFILM Irvine Scientific Announces Construction of a New Cell Culture Media Manufacturing Site in Europe

By Leave a Comment

New facility brings rapid, reliable delivery of cell culture media to European customers

FUJIFILM Irvine Scientific - Product Manager Job PostSANTA ANA, California – July 2, 2019: FUJIFILM Irvine Scientific, Inc., a global leader in the innovation, development, and manufacture of cell culture media, announced plans to open a third manufacturing facility located in Tilburg, Netherlands. The company currently has sites in the United States and Japan. Fujifilm’s investment in this project demonstrates its commitment to accelerate development in bioproduction, and cell and gene therapy markets. [Read more…]

BioInformant's World-Class Clients